This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n10http://linked.opendata.cz/resource/drugbank/drug/DB08504/identifier/pdb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB08504/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08504/identifier/pubchem-substance/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08504/identifier/drugbank/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08504/identifier/chemspider/
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n5http://linked.opendata.cz/ontology/drugbank/
owlhttp://www.w3.org/2002/07/owl#
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB08504
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n4:DB08504 n14:DB08504
dcterms:title
6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM
adms:identifier
n9:99444975 n10:S14 n11:10320144 n12:8495608 n13:DB08504
n5:IUPAC-Name
n6:271B5E80-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B5E86-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B5E85-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B5E82-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B5E83-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B5E84-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B5E7E-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B5E7F-363D-11E5-9242-09173F13E4C5 n6:271B5E7C-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B5E7D-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B5E8C-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B5E8D-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B5E87-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B5E88-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B5E8A-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B5E89-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B5E8B-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B5E92-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B5E94-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B5E95-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B5E91-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B5E90-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B5E93-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B5E81-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B5E8E-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B5E8F-363D-11E5-9242-09173F13E4C5